The World Health Organization (WHO) warns that antimicrobial resistance (AMR) could cause 39 million deaths over the next 25 years.
Clinical Realities of Drug Resistance
- Treatment adherence is vital: Stopping a prescribed course early or using incorrect dosages allows bacteria to survive and develop resistance, rendering future treatments ineffective.
- The “Community” risk: Resistance is not just a personal health issue; resistant bacteria spread between individuals, meaning one person’s misuse of medication impacts the safety of the entire population.
The 39 Million Mortality Projection
The WHO’s latest alert, issued on Monday, outlines a stark trajectory for global health. Jean-Pierre Niemazy, a WHO expert, said that over one million people died directly from drug-resistant infections in 2021. Without systemic intervention, this figure is projected to climb to 39 million deaths over the next 25 years. The crisis is compounded by a lack of new antibiotic development, even as resistant pathogens proliferate.
The threat is particularly acute for vulnerable populations, including patients with cancer or chronic conditions. These individuals are more susceptible to infections caused by bacteria, viruses, or fungi that no longer respond to available therapeutic agents.

Nations Fall Behind WHO Infection Prevention Targets
Current data shows large gaps in the global response. According to the WHO, only slightly more than one-third of nations currently implement the organization’s infection prevention guidelines in full. Many countries remain far behind the 2030 targets set at the 2024 World Health Assembly, which include mandates for improved diagnostic testing, surveillance of resistant strains, and stricter hospital-based drug management.
| Metric | Current Status / Projection |
|---|---|
| 2021 Direct AMR Deaths | Over one million |
| Projected AMR Deaths (25-Year Horizon) | 39 million |
| Compliance with WHO Prevention Rules | Slightly more than one-third of countries |
Diagnostic Tools Determine If a Prescription Is Indicated
Professional diagnostic tools—such as bacterial cultures, antigen testing, or urinalysis—are the reliable methods to determine if a prescription is clinically indicated.
The Future of Antimicrobial Stewardship
As noted in the KLİMİK podcast, the future of medical treatment options is being shaped by every decision made in the clinic today. Without a coordinated effort to improve testing capacity and adhere to established stewardship protocols, the clinical utility of our current antibiotic arsenal will continue to diminish, potentially reversing decades of progress in modern medicine.